Radboud Universitair Medisch Centrum

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Aortic stenosis1 trial
• Bladder cancer1 trial
• Cervical cancer1 trial
• Duchenne muscular dystrophy1 trial
• Friedreich ataxia1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• IgA nephropathy1 trial
• Liver and biliary tract cancer1 trial
• Macular degeneration1 trial
• Obesity1 trial
• and 3 more

Phase

• Phase 34 trials
• Phase 13 trials
• Phase 1/21 trial
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting6 trials
• Terminated3 trials
• Completed1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Amgen4 trials
• Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 trial
• Biogen1 trial
• Gyroscope Therapeutics Limited1 trial
• Kyntra Bio1 trial
• and 4 more

Running trials

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Active, not recruiting

  A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

  NCT06953583· Phase 3· Biogen· Source

• Active, not recruiting

  REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

  NCT06557798· The Leeds Teaching Hospitals NHS Trust· Source

• Recruiting

  Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245· Phase 3· OSE Immunotherapeutics· Source

  Contact: Caroline Chevalier, MSc, MPH

• Active, not recruiting

  Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

  NCT06333951· Phase 1· Amgen· Source

• Active, not recruiting

  A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

  NCT06360354· Phase 1· Amgen· Source

• Enrolling by invitation

  Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

  NCT05248659· Phase 2/3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Active, not recruiting

  Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer

  NCT03764553· Phase 2· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy1 recruiting
• Lung cancer1 recruiting

Closed trials

• Terminated

  A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05325866· Phase 1/2· Amgen· Source

• Completed

  Pre-operative Immunotherapy in Stage II-III Urothelial Cancer

  NCT04871594· Phase 1· The Netherlands Cancer Institute· Source

• Terminated

  Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD

  NCT04632940· Phase 3· Kyntra Bio· Source

• Terminated

  GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

  NCT03894020· Gyroscope Therapeutics Limited· Source